LOXL1 rs3825942: What Your Genotype Means
The rs3825942 variant is a specific change in the LOXL1 gene that has been extensively studied for its association with pseudoexfoliation syndrome (PEX). This condition involves the accumulation of abnormal protein deposits in the eye, which can increase the risk of developing secondary glaucoma.
What each genotype means
Lower glaucoma risk
This genotype is associated with a significantly lower risk of developing pseudoexfoliation syndrome and associated glaucoma compared to the G allele. Research indicates this variant may provide a protective effect against these specific eye conditions in many global populations. Please note that this association does not protect against other forms of glaucoma or eye disease.
This genotype is less common than the G/G genotype in many European and North American cohorts.
Intermediate risk profile
Carrying one copy of the A allele and one copy of the G allele results in an intermediate risk profile for pseudoexfoliation syndrome. The G allele is the primary risk factor associated with this condition, while the A allele is considered protective. You should discuss your overall eye health and any family history of glaucoma with your ophthalmologist.
This heterozygous genotype is found at varying frequencies across different global populations.
Higher glaucoma risk
This genotype is strongly associated with an increased risk of developing pseudoexfoliation syndrome and secondary glaucoma in many populations worldwide. While this is a well-established genetic association, it is not a diagnosis, and many individuals with this genotype will not develop the condition. Regular comprehensive eye examinations are recommended to monitor for early signs of glaucoma.
This is a common genotype in many European and North American populations, though its association with disease risk can vary significantly in other ancestries, such as in certain South African populations.
Understanding the rs3825942 Variant
The rs3825942 variant is a single nucleotide polymorphism (SNP) located within the first exon of the LOXL1 gene on chromosome 15. In genetic terms, this variant is a missense mutation, meaning it results in a change to the amino acid sequence of the protein produced by the gene. Specifically, it causes a substitution where glycine is replaced by aspartic acid at position 153 (often referred to as G153D). Because this variant is located in a coding region, researchers have long investigated whether this structural change directly alters the function of the LOXL1 protein. While it is a well-documented marker for eye-related traits, recent studies suggest that it may also act as a proxy for other nearby regulatory variants that influence how the gene is expressed, rather than being the sole cause of the observed clinical associations.
The Role of the LOXL1 Gene
The LOXL1 gene provides instructions for making the lysyl oxidase-like 1 protein. This enzyme plays a critical role in the formation and maintenance of elastic fibers in the body's connective tissues. Elastic fibers are essential for the structural integrity of many tissues, including the trabecular meshwork of the eye, which acts as a drainage system for ocular fluid. When LOXL1 function is impaired, the homeostasis of these elastic fibers can be disrupted. This disruption is thought to lead to the accumulation of abnormal, fibrillar material characteristic of pseudoexfoliation syndrome. By affecting the extracellular matrix, variations in LOXL1 may compromise the eye's ability to regulate internal pressure, which is a primary concern in the development of secondary glaucoma. Understanding this gene helps researchers map the biological pathways that lead from genetic predisposition to clinical ocular symptoms.
Research and Evidence Strength
The association between rs3825942 and pseudoexfoliation syndrome is supported by numerous studies across diverse populations, including European, Japanese, and Chinese cohorts. In many of these studies, the G allele of rs3825942 has shown a strong statistical correlation with an increased risk of developing the syndrome and associated glaucoma. However, the evidence is considered complex because the risk alleles for this variant can vary significantly between different ancestral groups. Furthermore, some researchers argue that because the variant is in high linkage disequilibrium with other nearby SNPs, it may not be the functional driver of the disease. While the statistical association is robust in many clinical settings, the biological mechanism remains a subject of ongoing investigation. As with many complex traits, having a specific genotype does not guarantee the development of a condition, as environmental factors and other genetic modifiers also play significant roles.
Population Frequency
The frequency of the rs3825942 alleles varies significantly across global populations. In many European cohorts, the risk-associated alleles are quite common, with allele frequencies often reported in the range of 0.80 to 0.85. Because these alleles are prevalent in the general population, the presence of the variant alone is not a diagnostic tool for disease. Researchers often compare the frequency of these alleles in individuals with pseudoexfoliation syndrome against healthy control groups to determine the strength of the association. It is important to note that while the variant is common, the actual incidence of clinical pseudoexfoliation syndrome is much lower, highlighting that genetic predisposition is only one piece of a larger puzzle involving age, environment, and other biological factors.
What This Information Means for You
Genetic information regarding rs3825942 is primarily used in research settings to understand the biological basis of eye health. It is not a diagnostic test for glaucoma or pseudoexfoliation syndrome. If you have concerns about your eye health, particularly if you have a family history of glaucoma or vision changes, it is essential to consult with an ophthalmologist or a qualified eye care professional. They can perform clinical examinations, such as measuring intraocular pressure and inspecting the structures of the eye, which are the standard methods for assessing risk and managing eye conditions. You should never use genetic data to make medical decisions or to self-diagnose. Always discuss any findings from genetic reports with a healthcare provider who can interpret them in the context of your overall health history and clinical presentation.
How common is this variant?
The rs3825942 variant is common, with the risk-associated allele frequency typically ranging from 0.80 to 0.85 in European populations.
Frequently asked questions
Is rs3825942 a diagnostic test for glaucoma?
No, rs3825942 is not a diagnostic test. It is a genetic marker associated with a higher statistical risk of pseudoexfoliation syndrome, but it cannot predict whether an individual will develop glaucoma.
What should I do if I have the GG genotype?
The GG genotype is a common genetic finding. If you are concerned about your eye health, you should schedule a comprehensive eye exam with an ophthalmologist to monitor your ocular health, regardless of your genetic results.
Does this variant cause blindness?
The variant is associated with pseudoexfoliation syndrome, which is a risk factor for glaucoma. Glaucoma can lead to vision loss if left untreated, but having the variant does not mean you will experience vision loss.
Why do different studies show different risk levels?
Genetic associations can vary between populations due to differences in genetic background and environmental factors. Additionally, some variants may be markers for other nearby functional changes, leading to varying results across studies.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3825942?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in LOXL1
This LOXL1 variant is associated with exfoliation syndrome (XFS) and exfoliation glaucoma (XFG), though recent evidence suggests it may act as a proxy for other functional variants in the locus rather than being directly causative.
Common missense variant (Arg141Leu) in LOXL1 historically associated with pseudoexfoliation syndrome; recent evidence suggests these variants may be proxies for other causative regulatory variants.
Missense variant in LOXL1 associated with pseudoexfoliation syndrome and glaucoma.
Exonic missense variant (p.Gly153Asp) in LOXL1 conferring major risk for pseudoexfoliation syndrome and secondary glaucoma.
Common missense variant (Arg141Leu) in LOXL1; strongly associated with exfoliation syndrome and glaucoma.
A missense variant (p.Gly153Asp) in LOXL1 strongly associated with pseudoexfoliation syndrome and secondary open-angle glaucoma.